NDC Pharmacologic Class N0000182964 Bradykinin B2 Receptor Antagonists [MoA]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0093-3066Icatibant IcatibantInjection, SolutionSubcutaneousTeva Pharmaceuticals Usa, Inc.Human Prescription Drug
24201-207Icatibant IcatibantInjection, SolutionSubcutaneousLeucadia PharmaceuticalsHuman Prescription Drug
54092-135Icatibant IcatibantInjection, SolutionSubcutaneousTakeda Pharmaceuticals America, Inc.Human Prescription Drug
54092-702Firazyr Icatibant AcetateInjection, SolutionSubcutaneousTakeda Pharmaceuticals America, Inc.Human Prescription Drug
60505-6214Icatibant Icatibant AcetateInjection, SolutionSubcutaneousApotex Corp.Human Prescription Drug
63323-574Icatibant IcatibantInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcHuman Prescription Drug
68462-828Icatibant Icatibant AcetateInjection, SolutionSubcutaneousGlenmark Pharmaceuticals Inc., UsaHuman Prescription Drug
69097-664Icatibant IcatibantInjectionSubcutaneousCipla Usa Inc.Human Prescription Drug
70709-013Sajazir IcatibantInjectionSubcutaneousCycle Pharmaceuticals Ltd-ukHuman Prescription Drug
71225-114Icatibant IcatibantInjectionSubcutaneousSlayback Pharma LlcHuman Prescription Drug

There are 10 NDC products with the pharmacologic class Bradykinin B2 Receptor Antagonists [MoA].